Caspase 3 (CASP3) Mouse Monoclonal Antibody [Clone ID: CPP32 4-1-18]
Frequently bought together (3)
Recombinant protein of human caspase 3, apoptosis-related cysteine peptidase (CASP3), transcript variant beta
USD 823.00
Transient overexpression lysate of caspase 3, apoptosis-related cysteine peptidase (CASP3), transcript variant beta
USD 396.00
Other products for "Caspase 3"
Specifications
Product Data | |
Clone Name | CPP32 4-1-18 |
Applications | IHC, WB |
Recommended Dilution | Immunohistochemistry-Frozen, Western Blot: 1:500-1:1000, Simple Western: 1:2000, Immunohistochemistry-Paraffin: 1:10-1:500, Immunohistochemistry: 1:200-1:500, Immunoprecipitation: 2 ug / mg lysate, Immunocytochemistry/ Immunofluorescence: 2 ug/ml |
Reactivities | Human |
Host | Mouse |
Isotype | IgG2a, kappa |
Clonality | Monoclonal |
Immunogen | Full-length recombinant human Caspase 3 protein. |
Formulation | 0.1% sodium azide |
Purification | Affinity purified |
Conjugation | Unconjugated |
Storage | Store at -20°C as received. |
Stability | Stable for 12 months from date of receipt. |
Gene Name | caspase 3 |
Database Link | |
Background | Caspases are cysteine proteases, expressed as inactive precursors, that mediate apoptosis by proteolysis of specific substrates. Caspases have the ability to cleave after aspartic acid residues. There are two classes of caspases involved in apoptosis; initiators (activation by receptor cluster) and effectors (activation by mitochondrial permeability transition). Proapoptotic signals autocatalytically activate initiator caspases, such as Caspase-8 and Caspase-9. Activated initiator caspases then process effector caspases, such as Caspase-3 and Caspase-7, which in turn cause cell collapse. |
Synonyms | CPP32; CPP32B; SCA-1 |
Reference Data | |
Protein Families | Druggable Genome, ES Cell Differentiation/IPS, Protease |
Protein Pathways | Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Apoptosis, Colorectal cancer, Epithelial cell signaling in Helicobacter pylori infection, Huntington's disease, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, p53 signaling pathway, Parkinson's disease, Pathways in cancer, Viral myocarditis |
Documents
Product Manuals |
FAQs |
SDS |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.